Literature DB >> 25589962

Predictive risk factors for lymph node metastasis in patients with small size non-small cell lung cancer.

Feichao Bao1, Ping Yuan1, Xiaoshuai Yuan1, Xiayi Lv1, Zhitian Wang1, Jian Hu1.   

Abstract

BACKGROUND: Accurate clinical staging of non-small cell lung cancer (NSCLC) is essential for developing an optimal treatment strategy. This study aimed to determine the predictive risk factors for lymph node metastasis, including both N1 and N2 metastases, in clinical T1aN0 NSCLC patients.
METHODS: We retrospectively evaluated clinical T1aN0M0 NSCLC patients who showed no radiologic evidence of lymph node metastasis, and who had undergone surgical pulmonary resection with systematic mediastinal node dissection or sampling at the First Affiliated Hospital of Zhejiang University between January 2011 and June 2013. Univariate and multivariate logistic regression analyses were performed to identify predictive factors for node metastasis.
RESULTS: Pathologically positive lymph nodes were found in 16.2% (51/315) of the patients. Positive N1 nodes were found in 12.4% (39/315) of the patients, and positive N2 nodes were identified in 13.0% (41/315) of the patients. Some 9.2% (29/315) of the patients had both positive N1 and N2 nodes, and 3.8% (12/315) of the patients had nodal skip metastasis. Variables of preoperative radiographic tumor size, non-upper lobe located tumors, high carcinoembryonic antigen (CEA) levels and micropapillary predominant adenocarcinoma (AC) were identified as predictors for positive N1 or N2 node multivariate analysis.
CONCLUSIONS: Pathologically positive lymph nodes were common in small size NSCLC patients with clinical negative lymph nodes. Therefore, preoperative staging should be performed more thoroughly to increase accuracy, especially for patients who have the larger size, non-upper lobe located, high CEA level or micropapillary predominant ACs.

Entities:  

Keywords:  Non-small cell lung cancer (NSCLC); lymph node metastasis; sublobar resections

Year:  2014        PMID: 25589962      PMCID: PMC4283338          DOI: 10.3978/j.issn.2072-1439.2014.11.05

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  22 in total

1.  Peripheral small-sized (2 cm or less) non-small cell lung cancer with mediastinal lymph node metastasis; clinicopathologic features and patterns of nodal spread.

Authors:  Shun-ichi Watanabe; Makoto Oda; Yoshio Tsunezuka; Tetsuhiko Go; Yasuhiko Ohta; Go Watanabe
Journal:  Eur J Cardiothorac Surg       Date:  2002-12       Impact factor: 4.191

Review 2.  Neoadjuvant therapy for resectable non-small cell lung cancer with mediastinal lymph node involvement.

Authors:  Brandon H Tieu; Rachel E Sanborn; Charles R Thomas
Journal:  Thorac Surg Clin       Date:  2008-11       Impact factor: 1.750

3.  Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group.

Authors:  R J Ginsberg; L V Rubinstein
Journal:  Ann Thorac Surg       Date:  1995-09       Impact factor: 4.330

4.  The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival.

Authors:  Arne Warth; Thomas Muley; Michael Meister; Albrecht Stenzinger; Michael Thomas; Peter Schirmacher; Philipp A Schnabel; Jan Budczies; Hans Hoffmann; Wilko Weichert
Journal:  J Clin Oncol       Date:  2012-03-05       Impact factor: 44.544

5.  Randomized phase III study of surgery alone or surgery plus preoperative cisplatin and gemcitabine in stages IB to IIIA non-small-cell lung cancer.

Authors:  Giorgio V Scagliotti; Ugo Pastorino; Johan F Vansteenkiste; Lorenzo Spaggiari; Francesco Facciolo; Tadeusz M Orlowski; Luigi Maiorino; Martin Hetzel; Monika Leschinger; Carla Visseren-Grul; Valter Torri
Journal:  J Clin Oncol       Date:  2011-11-28       Impact factor: 44.544

6.  Utility of endobronchial ultrasound-guided mediastinal lymph node biopsy in patients with non-small cell lung cancer.

Authors:  Benjamin E Lee; Elaine Kletsman; John R Rutledge; Robert J Korst
Journal:  J Thorac Cardiovasc Surg       Date:  2011-12-10       Impact factor: 5.209

7.  Clinicopathologic study of resected, peripheral, small-sized, non-small cell lung cancer tumors of 2 cm or less in diameter: pleural invasion and increase of serum carcinoembryonic antigen level as predictors of nodal involvement.

Authors:  Masayoshi Inoue; Masato Minami; Hiroyuki Shiono; Noriyoshi Sawabata; Kan Ideguchi; Meinoshin Okumura
Journal:  J Thorac Cardiovasc Surg       Date:  2006-05       Impact factor: 5.209

8.  Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis.

Authors:  Amgad El-Sherif; William E Gooding; Ricardo Santos; Brian Pettiford; Peter F Ferson; Hiran C Fernando; Susan J Urda; James D Luketich; Rodney J Landreneau
Journal:  Ann Thorac Surg       Date:  2006-08       Impact factor: 4.330

9.  Lymph node involvement, recurrence, and prognosis in resected small, peripheral, non-small-cell lung carcinomas: are these carcinomas candidates for video-assisted lobectomy?

Authors:  H Asamura; H Nakayama; H Kondo; R Tsuchiya; Y Shimosato; T Naruke
Journal:  J Thorac Cardiovasc Surg       Date:  1996-06       Impact factor: 5.209

10.  Prediction of pathologic node-negative clinical stage IA lung adenocarcinoma for optimal candidates undergoing sublobar resection.

Authors:  Yasuhiro Tsutani; Yoshihiro Miyata; Haruhiko Nakayama; Sakae Okumura; Shuji Adachi; Masahiro Yoshimura; Morihito Okada
Journal:  J Thorac Cardiovasc Surg       Date:  2012-08-09       Impact factor: 5.209

View more
  22 in total

1.  Evidence for Expanding Invasive Mediastinal Staging for Peripheral T1 Lung Tumors.

Authors:  Emily A DuComb; Benjamin A Tonelli; Ya Tuo; Bernard F Cole; Vitor Mori; Jason H T Bates; George R Washko; Raúl San José Estépar; C Matthew Kinsey
Journal:  Chest       Date:  2020-06-26       Impact factor: 9.410

2.  Risk analyses of N2 lymph-node metastases in patients with T1 non-small cell lung cancer: a multi-center real-world observational study in China.

Authors:  Bing Chen; Wenjie Xia; Zhongqiu Wang; Heng Zhao; Xiaofei Li; Lunxu Liu; Yang Liu; Jian Hu; Xiangning Fu; Yin Li; Yijun Xu; Deruo Liu; Haiying Yang; Lin Xu; Feng Jiang
Journal:  J Cancer Res Clin Oncol       Date:  2019-08-19       Impact factor: 4.553

3.  Recognition of "aggressive" behavior in "indolent" ground glass opacity and mixed density lesions.

Authors:  Junyan Zha; Dong Xie; Huikang Xie; Liping Zhang; Fangyu Zhou; Pengqing Ying; Lilan Zhao; Gening Jiang; Ke Fei; Chang Chen
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

4.  Intratumoral lymph vessel invasion as a predictive risk factor for nodal metastasis in non-small cell lung cancer: should L-1 status obligate adjuvant chemotherapy?

Authors:  Kimberly J Song; Raja M Flores
Journal:  J Thorac Dis       Date:  2019-09       Impact factor: 2.895

5.  Clinicopathological Significance of Micropapillary Pattern in Lung Adenocarcinoma.

Authors:  Jung-Soo Pyo; Joo Heon Kim
Journal:  Pathol Oncol Res       Date:  2017-07-06       Impact factor: 3.201

6.  Dissection of the left paratracheal area is frequently missed during left side non-small cell lung cancer surgery.

Authors:  Gonzalo Varela; Marcelo F Jiménez
Journal:  J Thorac Dis       Date:  2019-05       Impact factor: 2.895

7.  Five-year survival analysis and prognostic factors in patients operated on for non-small cell lung cancer with N2 disease.

Authors:  Mariusz Łochowski; Barbara Łochowska; Marek Rębowski; Daniel Brzeziński; Bartosz Cieślik-Wolski; Józef Kozak
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

8.  18F-FDG PET-based radiomics model for predicting occult lymph node metastasis in clinical N0 solid lung adenocarcinoma.

Authors:  Lili Wang; Tiancheng Li; Junjie Hong; Mingyue Zhang; Mingli Ouyang; Xiangwu Zheng; Kun Tang
Journal:  Quant Imaging Med Surg       Date:  2021-01

9.  Time-to-Progression of NSCLC from Early to Advanced Stages: An Analysis of data from SEER Registry and a Single Institute.

Authors:  Ping Yuan; Jin Lin Cao; Azmat Rustam; Chong Zhang; Xiao Shuai Yuan; Fei Chao Bao; Wang Lv; Jian Hu
Journal:  Sci Rep       Date:  2016-06-27       Impact factor: 4.379

Review 10.  Clinical impacts of a micropapillary pattern in lung adenocarcinoma: a review.

Authors:  Ying Cao; Li-Zhen Zhu; Meng-Jie Jiang; Ying Yuan
Journal:  Onco Targets Ther       Date:  2015-12-31       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.